FDA Withdraws Direct-To-Consumer Ad Guidance, As It Develops Social Media Documents

Agency reps updated stakeholders on guidance development efforts related to advertising and promotion during a Food and Drug Law Institute conference in Washington, D.C.

More from Regulation

More from Policy & Regulation